Ponatinib hydrochloride

CAS No.	1114544-31-8	Cat. No.	BCP10906
Name	Ponatinib hydrochloride
Synonyms	AP24534 HCl; AP-24534 HCl; AP 24534 HCl; Ponatinib HCl; Ponatinib Mono-hydrochloride;
Formula	C29H28ClF3N6O	M. Wt	569.02

Description	Ponatinib Hydrochloride is the hydrochloride salt form of an orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Ponatinib inhibits unmutated and all mutated forms of Bcr-Abl, including T315I, the highly drug therapy-resistant missense mutation of Bcr-Abl. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs); in addition, it inhibits the tyrosine kinase receptor TIE2 and FMS-related tyrosine kinase receptor-3 (Flt3). RTK inhibition by ponatinib may result in the inhibition of cellular proliferation and angiogenesis and may induce cell death. Bcr-Abl is a fusion tyrosine kinase encoded by the Philadelphia chromosome.
Pathways	Angiogenesis/Protein Tyrosine Kinase
Targets	Src/Bcr Abl PDGFR VEGFR FGFR

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.